The Surgeon'sNotebook

Fluid timing, caffeine, alcohol, double voiding, bladder training and a symptom diary: what self-care can and cannot do, and when it is time for more.

Alternatives, surgeon experience, nerve-sparing, continence, erections, the catheter and follow-up: what to ask, and what a good answer sounds like. With a printable checklist.

What the first three months feel like after robotic partial or radical nephrectomy: hospital stay, tiredness, driving, work, and the warning signs that mean you should call your team.

A PI-RADS score is not a diagnosis. What scores of 3, 4 and 5 mean, when a targeted biopsy is advised, and the questions to ask about your MRI report.

A high RENAL score describes a complex tumour, not an aggressive cancer, and it does not automatically mean losing the whole kidney. What the score measures and how the decision is made.

The practical advice Mr Sri gives in clinic: walking, fluids, fibre, pelvic floor exercises and catheter care, plus the warning signs that mean you should call your team.

Robotic colposuspension is a mesh-free keyhole operation that uses the same proven Burch principle with robotic precision. Written by Mr Denosshan Sri and Mr Jai Seth — who pioneered the procedure in the UK.

NanoKnife uses precision electrical pulses to destroy prostate cancer cells by disrupting their membranes — without cutting, heating, or freezing. This article explains the IRE mechanism, who is a genuine candidate, and what the NICE position means in practice.

Focal One HIFU uses robotic, computer-guided focused ultrasound to ablate the cancer-bearing zone of the prostate without removing the whole gland. This article explains how it works, who is genuinely suitable, and how it compares with surgery, radiotherapy and active surveillance.

Partial nephrectomy is NICE's preferred treatment for a 3cm kidney tumour when feasible — but tumour location changes everything about what is surgically possible. This article explains all options including complex kidney-sparing robotic surgery.

Retzius-sparing prostatectomy uses a posterior surgical approach that preserves front bladder support structures — with consistent evidence for earlier return of urinary continence compared with the standard technique.

Focal therapy targets only the cancer-bearing zone of the prostate — potentially reducing side effects compared with whole-gland treatment. This guide explains how each method works, who is a genuine candidate, and what the 2024 evidence shows.

The UK's first targeted prostate cancer screening programme was recommended in June 2026. It covers a tightly defined group. Most high-risk men — including Black men — are still not in a formal programme. Here is what to do.

The T staging letters follow a clear logic once you understand that T1 and T2 measure size, while T3 measures local spread — and a small T3 tumour (with vein involvement) can outrank a much larger T2.

Erections often take time to recover after radical prostatectomy — and many men need active rehabilitation. This guide explains nerve-sparing, recovery timelines, and the treatments that support erectile function after surgery.

A PSA of 10 ng/mL is above the standard threshold and warrants prompt assessment — but it is not a diagnosis. Age, prostate size, trend, and MRI findings all shape what happens next.

Blood in the urine is the most consistent warning sign of bladder cancer. One episode is enough to justify urgent assessment. This article explains the diagnosis pathway, cystoscopy, TURBT, and how treatment matches stage.

A plain, honest guide to vasectomy — covering the procedure itself, what the recovery involves, when it becomes effective, and what it does not change about sexual function.

All four are established BPH treatments — but they are not interchangeable. Prostate size, symptom severity, and priorities around ejaculation all determine which option fits. A plain-language guide to the differences.

The standard approach for prostate sampling in the UK — with lower infection risk than older methods, and usually far more manageable than patients expect. A step-by-step guide to what happens and how to prepare.

Most kidney cysts found on scans are entirely harmless. Kidney tumours are different — but many are caught early and highly treatable. This article explains what imaging shows, the Bosniak classification, and when to seek specialist review.

PSA 3 ng/mL sits in a genuine grey zone — below the classic referral threshold but not automatically reassuring. Age, trend, prostate size, and risk factors all determine what it means for you.

What really happens after robotic prostatectomy — catheter care, urinary leakage, PSA surveillance, penile rehabilitation, and building confidence through the first two months and beyond.

Both treatments offer equivalent cancer control for many men. The choice turns on side effects, recovery, and what trade-offs you can live with — explained clearly and honestly.

For many kidney tumours, partial nephrectomy preserves the kidney while achieving equivalent cancer control. This article explains who is suitable, how robotic surgery works, and what the decision involves.

A raised PSA is a signal, not a diagnosis. This article explains what 5 ng/mL means at different ages, the common non-cancer causes, and the step-by-step assessment pathway.

Blood in the urine should always prompt investigation. This guide covers what counts as haematuria, when to act urgently, and what specialist assessment involves from first appointment to diagnosis.

One in three women experience urinary incontinence. This guide covers the spectrum of treatment — from pelvic floor physiotherapy through to mesh-free robotic colposuspension — in plain language.

Why approaching the kidney from behind — without entering the abdominal cavity — can mean faster recovery and better access to posterior tumours. Published personal outcomes included.

The complete diagnostic and treatment pathway — from PSA assessment and mpMRI through to robotic prostatectomy, active surveillance, and survivorship.